Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrauterine hCG before embryo transfer in women with prior embryo transfer failure
IRCT20250201064590N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Feb 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label trial of human chorionic gonadotropin in infertility (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Chemical pregnancy and Ongoing pregnancy. Started Feb 2025; status: completed.
02
Drugs
human chorionic gonadotropin
03
Conditions
infertility
Beyond the preview
Go deeper on IRCT20250201064590N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250201064590N1.